Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ: LNTH )

92.62 -2.03 (-2.14%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
What 4 Analyst Ratings Have To Say About Lantheus Holdings
Via Benzinga
Why Lantheus Holdings (LNTH) Stock Is Down 4%
Lantheus shares are trading lower by 5.4% during Monday's session. The company announced a $350 million acquisition. 
Via Benzinga
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
Investors should take note ofLANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock that remains attractively priced. 
Via Chartmill
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level. 
Via Investor's Business Daily
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating. 
Via Chartmill
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
P/E Ratio Insights for Lantheus Holdings
Via Benzinga
Here's How Much You Would Have Made Owning Lantheus Holdings Stock In The Last 5 Years
Via Benzinga
For those who appreciate value investing, NASDAQ:LNTH is a compelling option with its solid fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying. 
Via Chartmill
2 Stock Market Predictions for 2025: 2 Stocks Worth Buying No Matter What Happens
Short-term market predictions are fun, but rarely worth investing in. Here are two stocks we think will be winners no matter what happens with the market in 2025. 
Via The Motley Fool
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable. 
Via Chartmill
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Why NASDAQ:LNTH Is a Promising High-Growth Stock in the Midst of Consolidation.
Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
How Is The Market Feeling About Lantheus Holdings?
Via Benzinga
Why Lantheus Holdings Stock Won Big on Wednesday
Via The Motley Fool
How Is The Market Feeling About Lantheus Holdings?
Via Benzinga
Despite its growth, NASDAQ:LNTH remains within the realm of affordability.
NASDAQ:LNTH stands out as a growth opportunity that won't break the bank. 
Via Chartmill
Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.
Despite its growth, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) remains within the realm of affordability. 
Via Chartmill
Lantheus Announces Share Repurchase Program
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present at the Jefferies London Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
NASDAQ:LNTH stands out as a stock that provides good value for the fundamentals it showcases.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): good value for what you're paying. 
Via Chartmill
After Trump's Win, It's Time To Take Profits On Gold
Via Benzinga
Topics Government
Exposures Political
Peering Into Lantheus Holdings's Recent Short Interest
Via Benzinga
NASDAQ:LNTH, a strong growth stock, setting up for a breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout. 
Via Chartmill
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
From Lantheus Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Lantheus Reports Third Quarter 2024 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
From Lantheus Holdings, Inc.
Via GlobeNewswire
Jim Cramer Likes Cava Group, Calls This Utilities Stock 'Terrific'
On Oct. 29, Citigroup analyst Jon Tower maintained Cava Group with a Neutral and raised the price target from $115 to $140. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.